Depressive symptoms and sex differences in the risk of post-COVID-19 persistent symptoms: a prospective population-based cohort study-Reference-Cited by-同舟云学术

Depressive symptoms and sex differences in the risk of post-COVID-19 persistent symptoms: a prospective population-based cohort study

Published:2024-07-17 Issue:9 Volume:2 Page:1053-1061
ISSN:2731-6076
Container-title:Nature Mental Health
language:en
Short-container-title:Nat. Mental Health

Author:

Matta Joane,Pignon Baptiste,Kab Sofiane,Wiernik Emmanuel,Robineau Olivier,Carrat Fabrice,Severi Gianluca,Touvier Mathilde,Blanché Hélène,Deleuze Jean-François,Gouraud Clément,Ouazana Vedrines Charles^ORCID,Pitron Victor,Tebeka Sarah,Ranque Brigitte,Hoertel Nicolas,Goldberg Marcel^ORCID,Zins Marie,Lemogne Cédric^ORCID

Funder

ANRS|MIE and Fondation de l'AP-HP

Fondation de l'AP-HP

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s44220-024-00290-6.pdf

Reference35 articles.

1. Robineau, O. et al. Long-lasting symptoms after an acute COVID-19 infection and factors associated with their resolution. JAMA Netw. Open 5, e2240985 (2022).

2. Ballering, A. V., van Zon, S. K. R., Olde Hartman, T. C., Rosmalen, J. G. M. & Lifelines Corona Research Initiative. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet 400, 452–461 (2022).

3. Al-Aly, Z., Bowe, B. & Xie, Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 28, 1461–1467 (2022).

4. Sylvester, S. V. et al. Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review. Curr. Med. Res. Opin. 38, 1391–1399 (2022).

5. Luo, D. et al. Prevalence and risk factors for persistent symptoms after COVID-19: a systematic review and meta-analysis. Clin. Microbiol. Infect. 30, 328–335 (2024).